ERBB2 and neoplasm: HER2 positivity was not statistically associated (p = 0.063) with the histological grade of the tumor; 50% of well differentiated and 30% of moderately differentiated tumors tested positive for HER2 compared with 19% of poorly differentiated tumors (Table 2).